ACCESSION: MSBNK-SMB_Measured-HSA015P0137000
RECORD_TITLE: Annotated; Hypoxanthine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 45
COMMENT: RAW_SPEC {'EL17_pos_2475': {'bp': 5460647.0, 'sum': 9116300.0}, 'EL13_pos_1831': {'bp': 4996356.0, 'sum': 7207148.0}, 'EL21_pos_2475': {'bp': 3834346.0, 'sum': 6236185.0}, 'EL14_pos_1838': {'bp': 3748271.0, 'sum': 5422657.0}, 'EL06_pos_2487': {'bp': 3136951.0, 'sum': 5754530.0}, 'EL02_pos_2469': {'bp': 2196856.0, 'sum': 4311760.0}, 'EL01_pos_2481': {'bp': 2071697.0, 'sum': 3922480.0}, 'EL15_pos_2457': {'bp': 1970966.0, 'sum': 3989352.0}, 'EL03_pos_2721': {'bp': 1887370.0, 'sum': 3440219.0}, 'EL13_pos_2476': {'bp': 1872383.0, 'sum': 3539194.0}, 'EL14_pos_2463': {'bp': 1332424.0, 'sum': 2686721.0}, 'EL10_pos_2487': {'bp': 1311854.0, 'sum': 2449996.0}, 'EL01_pos_1786': {'bp': 1285141.0, 'sum': 2123733.0}, 'EL22_pos_2493': {'bp': 1194024.0, 'sum': 2652314.0}, 'EL15_pos_1785': {'bp': 1069965.0, 'sum': 1911866.0}, 'EL02_pos_1786': {'bp': 1013366.0, 'sum': 1834355.0}, 'EL12_pos_2457': {'bp': 962347.0, 'sum': 2000943.0}, 'EL02_pos_1843': {'bp': 930777.0, 'sum': 1714871.0}, 'EL18_pos_1785': {'bp': 848791.0, 'sum': 1597065.0}, 'EL12_pos_1786': {'bp': 725545.0, 'sum': 1369910.0}, 'EL19_pos_1797': {'bp': 663932.0, 'sum': 1411673.0}, 'EL21_pos_1785': {'bp': 625925.0, 'sum': 1288907.0}, 'EL17_pos_1831': {'bp': 625884.0, 'sum': 1360380.0}, 'EL17_pos_1773': {'bp': 613001.0, 'sum': 1290034.0}, 'EL14_pos_1781': {'bp': 596075.0, 'sum': 1196413.0}, 'EL22_pos_1802': {'bp': 523785.0, 'sum': 1182215.0}, 'EL08_pos_1797': {'bp': 488813.0, 'sum': 1088846.0}, 'EL13_pos_1775': {'bp': 466932.0, 'sum': 1012825.0}, 'EL11_pos_2465': {'bp': 464572.0, 'sum': 1241088.0}, 'EL03_pos_2175': {'bp': 415792.0, 'sum': 1065315.0}, 'EL20_pos_1785': {'bp': 389180.0, 'sum': 995007.0}, 'EL04_pos_1797': {'bp': 373547.0, 'sum': 910888.0}, 'EL15_pos_1844': {'bp': 350326.0, 'sum': 969191.0}, 'EL10_pos_1785': {'bp': 339232.0, 'sum': 854767.0}, 'EL06_pos_1797': {'bp': 332482.0, 'sum': 905121.0}, 'EL03_pos_2233': {'bp': 309402.0, 'sum': 826821.0}, 'EL23_pos_1809': {'bp': 282781.0, 'sum': 850435.0}, 'EL16_pos_1798': {'bp': 280251.0, 'sum': 791928.0}, 'EL18_pos_2548': {'bp': 276066.0, 'sum': 893494.0}, 'EL17_pos_2543': {'bp': 271513.0, 'sum': 938949.0}, 'EL18_pos_1843': {'bp': 270679.0, 'sum': 861823.0}, 'EL01_pos_1844': {'bp': 269382.0, 'sum': 813630.0}, 'EL13_pos_2549': {'bp': 268029.0, 'sum': 903437.0}, 'EL14_pos_2537': {'bp': 258377.0, 'sum': 913479.0}, 'EL24_pos_1816': {'bp': 221511.0, 'sum': 685397.0}}
COMMENT: RETENTION_TIME_STDEV 0.553
COMMENT: PRECURSOR_M/Z_RAW 137.045959
COMMENT: PRECURSOR_M/Z_STDEV 0.000060
COMMENT: PRECURSOR_IN_MS1 mz 137.045815; int 69.387; delta(ppm) 0.888741
COMMENT: PROPOSED_CHARGE_STATE +1; mz 138.049159; int 4.704; cor 0.906
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.198; C5H4N4O; [M+H]+; delta(ppm) 0.198473
COMMENT: PROPOSED_MF MS-FINDER 3.779; C5H4N4O; [M+H]+; delta(ppm) 0.195474
COMMENT: PROPOSED_MF MS-FINDER 2.488; C5H12S2; [M+H]+; delta(ppm) 3.613296
COMMENT: PROPOSED_MF SIRIUS5_Sirius 33.485; C5H4N4O; [M+H]+; delta(ppm) 0.195474
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.174; C4H8O5; [M+H]+; delta(ppm) 9.954456
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.828; C5H12S2; [M+H]+; delta(ppm) 3.613296
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H4N4O; [M+H]+; delta(ppm) 0.195474
COMMENT: PROPOSED_MF SIRIUS6_Sirius 47.061; C5H4N4O; [M+H]+; delta(ppm) 0.195474
COMMENT: PROPOSED_MF SIRIUS6_Sirius 37.997; C3H9N2O2P; [M+H]+; delta(ppm) -11.857046
COMMENT: PROPOSED_MF SIRIUS6_Sirius 35.335; C4H9ClN2O; [M+H]+; delta(ppm) -149035.445230
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.424; C2H5FN4O2; [M+H]+; delta(ppm) -8.142211
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.640; C7H6NO2; [M+H]+; delta(ppm) -9.601622
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.617; C4H8O5; [M+H]+; delta(ppm) 9.954456
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.791; CH7N5OP; [M+H]+; delta(ppm) -2.059994
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.037; C2H7ClN5; [M+H]+; delta(ppm) -149028.350628
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.615; C5H5F3N; [M+H]+; delta(ppm) 8.241116
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.012; C3H2N7; [M+H]+; delta(ppm) 9.992762
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H4N4O; [M+H]+; delta(ppm) 0.195474
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 32.000; FDGQSTZJBFJUBT-UHFFFAOYSA-N; C5H4N4O; Massbank:PS025202 6-OxopurineSarcineHXSarkineHypoxanthine enol6-HydroxypurineSarkinHypoxanthine
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 20.000; OFCNXPDARWKPPY-UHFFFAOYSA-N; C5H4N4O; Massbank:EQ333603 Allopurinol1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 4.000; JFZSDNLQDTYVEE-UHFFFAOYSA-N; C5H4N4O; Massbank:FIO00455 Allopurinol
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.155; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; OC=1N=CC2=NCN=C2N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.121; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; O=C1N=CNC2=C1NN=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.121; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; OC1=NC=NC2=C1N=NC2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.101; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; OC1=NC=NC2=C1NC=N2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.895; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; OC1=NC=C2N=CN=C2N1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.744; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.979; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; Allopurinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.843; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.755; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; CNP0440561
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.747; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.686; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M+H]+; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.623; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M+H]+; CNP0439982
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.596; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M+H]+; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.574; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.471; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.457; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.327; PUUCPZKSTXFGOC-UHFFFAOYSA-N; [M+H]+; Ethyl isopropyl disulfide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.327; SNGRPWPVGSSZGV-UHFFFAOYSA-N; [M+H]+; Ethyl propyl disulfide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.310; DPLYGYOSWLFGGY-UHFFFAOYSA-N; [M+H]+; 1-Pentanesulfenothioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.275; QTWVOHZEDPQFTP-MLHKIVSYNA-N; [M+H]+; UNPD3575
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.206; BBYNYNMPOUQKKS-UHFFFAOYSA-N; [M+H]+; 2,2-Bis(methylthio)propane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.154; KMTUBAIXCBHPIZ-UHFFFAOYSA-N; [M+H]+; pentane-1,5-dithiol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M+H]+; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.959; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.952; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M+H]+; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.939; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.918; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M+H]+; CNP0439982
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.910; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; CNP0440561
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.908; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; Allopurinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.900; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.899; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.898; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.893; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.899; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.419; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; 1,7-dihydropurin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.890; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3-hydroxytriazolo[4,5-b]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.148; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 3,7-dihydropurin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.147; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; QBKYWNHLILCGEI-UHFFFAOYSA-N; [M+H]+; 4-cyano-1H-imidazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.077; DHQDPICNDWFEBQ-UHFFFAOYSA-N; [M+H]+; 5H-pyrazolo[1,5-d][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.063; QICFIUZWDPJRQF-UHFFFAOYSA-N; [M+H]+; 1,6-dihydropyrazolo[3,4-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; DSZCQHJBMSIMNX-UHFFFAOYSA-N; [M+H]+; 3,6-dihydroimidazo[4,5-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.046; RBWFEMOYMLQPAV-UHFFFAOYSA-N; [M+H]+; 1,5-dihydropyrazolo[3,4-d]pyridazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; GLVYFVYELPFNQC-UHFFFAOYSA-N; [M+H]+; 6H-pyrazolo[5,1-c][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; JDPCCIANHKTFII-UHFFFAOYSA-N; [M+H]+; 6H-[1,2,4]triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; VNMKCHFGAZFWKI-UHFFFAOYSA-N; [M+H]+; 6H-[1,2,4]triazolo[4,3-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,6-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.021; CLGWVBPVZYVPMR-UHFFFAOYSA-N; [M+H]+; 2H-[1,2,4]triazolo[4,3-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; GXBDCPYXMVITMR-UHFFFAOYSA-N; [M+H]+; 1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.997; QMFPURRPZZSJPF-UHFFFAOYSA-N; [M+H]+; 3H-imidazo[2,1-f][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.985; RDHMBEKEDDDWOF-UHFFFAOYSA-N; [M+H]+; 4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; REINGZOTPYBONL-UHFFFAOYSA-N; [M+H]+; [1,2]oxazolo[5,4-d]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; GJDZQWVZICYPIT-UHFFFAOYSA-N; [M+H]+; [1,3]oxazolo[5,4-d]pyrimidin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.768; WKOSBXIJGCIJII-UHFFFAOYSA-N; [M+H]+; [1,2]oxazolo[4,5-b]pyrazin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -24.816; FDGQSTZJBFJUBT; [M+H]+; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -38.179; CRIZPXKICGBNKG; [M+H]+; 2-Purinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -49.704; JFZSDNLQDTYVEE; [M+H]+; Zyloprim (TN)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -60.469; YPDSIEMYVQERLJ; [M+H]+; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -81.049; JDPCCIANHKTFII; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -92.064; OFCNXPDARWKPPY; [M+H]+; Ailurial
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -105.277; DHQDPICNDWFEBQ; [M+H]+; AmbscX-046497
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.495; NYNNJBKGLLSTAZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -139.861; GXBDCPYXMVITMR; [M+H]+; [1,2,4]Triazolo[1,5-a]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.200; CYYQSLSRZGVVHE; [M+H]+; Purine 3-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -180.354; OGCXIHWGXUQTCQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -180.980; QBKYWNHLILCGEI; [M+H]+; ACMC-20amkb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.727; FPIRBHDGWMWJEP; [M+H]+; 1-Hydroxy-7-azabenzotriazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.711; AXEBUIBRUVSSHM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.448; FDGQSTZJBFJUBT; [M+H]+; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -19.234; FDGQSTZJBFJUBT; [M+H]+; Sarkin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -47.336; CRIZPXKICGBNKG; [M+H]+; 7H-purin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -62.172; JFZSDNLQDTYVEE; [M+H]+; 7-Hydroxypyrazolo[4,3-d]pyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -87.068; QICFIUZWDPJRQF; [M+H]+; 1,6-Dihydropyrazolo[3,4-d]pyridazin-2-ium-7-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -99.159; YPDSIEMYVQERLJ; [M+H]+; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -100.431; RBWFEMOYMLQPAV; [M+H]+; 1,5-Dihydropyrazolo[3,4-d]pyridazin-2-ium-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -108.142; DHQDPICNDWFEBQ; [M+H]+; Pyrazolo[1,5-d][1,2,4]triazin-4(5H)-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -110.465; NYNNJBKGLLSTAZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.430; ONMSHVSDDXZRPS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -115.113; JDPCCIANHKTFII; [M+H]+; 6H-[1,2,4]Triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.857; FDGQSTZJBFJUBT; [M+H]+; Sarkin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Hypoxanthine, FDGQSTZJBFJUBT-UHFFFAOYSA-N; Matching to 32 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (3), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (9), MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0000157;
CH$NAME: Hypoxanthine
CH$NAME: 3,7-dihydropurin-6-one
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C5H4N4O
CH$EXACT_MASS: 136.038511
CH$SMILES: C1=NC2=C(N1)C(=O)N=CN2
CH$IUPAC: InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)
CH$LINK: CHEBI CHEBI:17368
CH$LINK: HMDB HMDB0000157
CH$LINK: INCHIKEY FDGQSTZJBFJUBT-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:790
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.361
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 137.045814
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-1900000000-da0344b89a9fad6866a4
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0293173 10.0433 55.030025 0.8541 2.19 0.9751 38 f{C2H3N2}/4.41ppm,p-C3H2N2O1
  55.9345983 10.7393 55.935310 1.4124 9.60 -0.0289 35 ?
  65.0387111 7.5725 65.039450 1.3069 5.15 0.1070 32 f{C5H5}/2.07ppm,p-N4O1
  67.0292085 5.3899 67.029950 1.1637 1.28 0.9609 33 f{C3H3N2}/2.00ppm,p-C2H2N2O1
  67.0543735 13.4358 67.055115 0.9097 8.56 0.2597 40 ?
  69.0335770 11.2912 69.034320 1.0430 7.87 -0.0859 38 f{C4H5O1}/1.24ppm,p-C1N4
  78.9497975 71.4748 78.950530 0.6586 51.66 0.4620 44 ?
  79.0542878 16.0751 79.055020 1.0626 10.07 0.0970 41 ?
  79.9489402 32.6392 79.949670 0.8881 24.60 0.3349 43 ?
  81.0699036 15.7383 81.070630 0.8758 10.27 0.3596 41 ?
  82.0400068 12.6724 82.040730 0.9020 2.23 0.9801 40 f{C3H4N3}/0.41ppm,p-C2H1N1O1
  91.0542103 18.6613 91.054890 0.8676 13.09 -0.0422 40 ?
  93.0698533 14.7854 93.070520 1.2141 10.24 0.2911 39 ?
  94.0400000 63.6552 94.040660 0.5636 5.99 0.9895 45 f{C4H4N3}/0.28ppm,p-C1H1N1O1
  95.0491273 9.9603 95.049780 1.3256 6.13 0.3724 40 ?
  95.0854526 12.4186 95.086105 1.0938 8.20 0.0332 32 ?
  96.9602519 16.7851 96.960890 1.1551 12.34 0.1997 41 ?
  107.0491173 9.5536 107.049660 1.0556 5.58 0.2580 33 ?
  109.0106957 9.1703 109.011225 1.4769 5.97 0.0227 32 ?
  109.0648211 9.1227 109.065350 1.3203 5.63 0.2263 33 ?
  110.0349080 103.4485 110.035430 0.4271 9.70 0.9901 45 f{C4H4N3O1}/0.18ppm,p-C1H1N1
  110.0600232 9.0633 110.060545 1.2448 5.06 0.1964 36 ?
  114.9708862 88.7079 114.971370 0.7393 72.30 -0.0834 45 ?
  115.9699846 39.5785 115.970460 1.0434 29.47 0.0574 43 ?
  119.0352417 103.7748 119.035690 0.5461 9.47 0.9896 45 f{C5H3N4}/0.16ppm,p-H2O1
  121.0284654 12.1559 121.028895 1.3633 9.52 0.2332 38 ?
  136.0216765 98.7373 136.021940 0.6102 63.41 0.1701 44 ?
  136.0618064 109.0714 136.062070 0.6615 82.48 0.4004 44 ?
  137.0458638 999.0000 137.046130 0.3430 0.00 1.0000 45 f{C5H5N4O1}/0.56ppm,p
  137.9868763 46.4531 137.987145 0.6885 32.43 0.2629 40 ?
  138.0913811 32.1105 138.091650 1.0935 33.01 0.2011 40 ?
  138.9859687 21.9256 138.986240 1.4246 15.55 0.1196 39 ?
PK$NUM_PEAK: 32
PK$PEAK: m/z int. rel.int.
  55.029317 10.04 10
  55.934598 10.74 10
  65.038711 7.57 7
  67.029208 5.39 5
  67.054373 13.44 13
  69.033577 11.29 11
  78.949798 71.47 71
  79.054288 16.08 16
  79.948940 32.64 32
  81.069904 15.74 15
  82.040007 12.67 12
  91.054210 18.66 18
  93.069853 14.79 14
  94.040000 63.66 63
  95.049127 9.96 9
  95.085453 12.42 12
  96.960252 16.79 16
  107.049117 9.55 9
  109.010696 9.17 9
  109.064821 9.12 9
  110.034908 103.45 103
  110.060023 9.06 9
  114.970886 88.71 88
  115.969985 39.58 39
  119.035242 103.77 103
  121.028465 12.16 12
  136.021676 98.74 98
  136.061806 109.07 109
  137.045864 999.00 999
  137.986876 46.45 46
  138.091381 32.11 32
  138.985969 21.93 21
//
